Sujal Shah, Chief Executive Officer at CymaBay Therapeutics, Inc. (CBAY), sold 128,840 shares at $19.99 ($2.6M) on 2023-12-11, disclosed to the SEC on 2023-12-11.
Scheduled sale ($2.6M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.99 | 63,975 | $1.3M | 49.6% |
| 2 | $19.99 | 63,975 | $1.3M | 49.6% |
| 3 | $20.81 | 890 | $19K | 0.7% |
| Total | $20.00 avg | 128,840 | $2.6M | 100% |
| Filing → |
| CBAY | BUY | 2022-06-07 | $200K | — | Filing → |
| CBAY | BUY | 2019-10-15 | $22K | — | Filing → |
| CBAY | BUY | 2019-09-24 | $28K | — | Filing → |